Cargando…

Docosahexaenoic acid in ARSACS: observations in two patients

BACKGROUND: Spastic ataxia of Charlevoix-Saguenay is a neurodegenerative condition due to mutations in the SACS gene and without a cure. Attempts to treatments are scarce and limited to symptomatic drugs. CASE PRESENTATION: Two siblings harboring biallelic variants in SACS underwent oral supplementa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricca, Ivana, Tessa, Alessandra, Trovato, Rosanna, Bacci, Giacomo Maria, Santorelli, Filippo Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254735/ https://www.ncbi.nlm.nih.gov/pubmed/32466761 http://dx.doi.org/10.1186/s12883-020-01803-3

Ejemplares similares

Functional Transcriptome Analysis in ARSACS KO Cell Model Reveals a Role of Sacsin in Autophagy
por: Morani, Federica, et al.
Publicado: (2019)

Assessment of Sacsin Turnover in Patients With ARSACS: Implications for Molecular Diagnosis and Pathogenesis
por: Longo, Fabiana, et al.
Publicado: (2021)

Functional Network Profiles in ARSACS Disclosed by Aptamer-Based Proteomic Technology
por: Morani, Federica, et al.
Publicado: (2021)

A Variant in TBCD Associated with Motoneuronopathy and Corpus Callosum Hypoplasia: A Case Report
por: Caputo, Maria, et al.
Publicado: (2023)

Retinal nerve fibre layer thickness in ARSACS: myelination or hypertrophy?
por: Garcia-Martin, Elena, et al.
Publicado: (2013)

Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACS
por: Nethisinghe, Suran, et al.
Publicado: (2021)

Abnormal retinal thickening is a common feature among patients with ARSACS-related phenotypes
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2014)

Novel compound heterozygous mutation in SACS gene leads to a milder autosomal recessive spastic ataxia of Charlevoix‐Saguenay, ARSACS, in a Finnish family
por: Palmio, Johanna, et al.
Publicado: (2016)

ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia
por: Vermeer, Sascha, et al.
Publicado: (2008)

ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia
por: Vermeer, Sascha, et al.
Publicado: (2008)

A Chromosomal Deletion and New Frameshift Mutation Cause ARSACS in an African-American
por: Dougherty, Sean C., et al.
Publicado: (2018)

Cardiac magnetic resonance findings in neuronal ceroid lipofuscinosis: A case report
por: Todiere, Giancarlo, et al.
Publicado: (2022)

Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration
por: Bagaria, Jaya, et al.
Publicado: (2022)

The ARSACS disease protein sacsin controls lysosomal positioning and reformation by regulating microtubule dynamics
por: Francis, Vincent, et al.
Publicado: (2022)

Restoring calcium homeostasis in Purkinje cells arrests neurodegeneration and neuroinflammation in the ARSACS mouse model
por: Del Bondio, Andrea, et al.
Publicado: (2023)

Novel SPAST deletion and reduced DPY30 expression in a Spastic Paraplegia type 4 kindred
por: Racis, Loretta, et al.
Publicado: (2014)

Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum
por: Synofzik, Matthis, et al.
Publicado: (2013)

SACS Mutation-Positive Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay (ARSACS) from Kerala
por: Sheetal, S, et al.
Publicado: (2020)

Correction: The ARSACS disease protein sacsin controls lysosomal positioning and reformation by regulating microtubule dynamics
por: Francis, Vincent, et al.
Publicado: (2022)

Ophthalmic Diagnosis and Novel Management of Infantile Refsum Disease with Combination Docosahexaenoic Acid and Cholic Acid
por: Elghawy, Omar, et al.
Publicado: (2021)

Docosahexaenoic Acid Status in Pregnancy Determines the Maternal Docosahexaenoic Acid Status 3-, 6- and 12 Months Postpartum. Results from a Longitudinal Observational Study
por: Markhus, Maria Wik, et al.
Publicado: (2015)

Myoimaging in the NGS era: the discovery of a novel mutation in MYH7 in a family with distal myopathy and core-like features – a case report
por: Astrea, Guja, et al.
Publicado: (2016)

Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
por: Teopompi, Elisabetta, et al.
Publicado: (2019)

Effects of Docosahexaenoic Acid on Neurotransmission
por: Tanaka, Kazuhiro, et al.
Publicado: (2012)

Docosahexaenoic acid and the preterm infant
por: Smith, Stephanie L., et al.
Publicado: (2017)

The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast Cancer
por: Molfino, Alessio, et al.
Publicado: (2016)

Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Case Report of a Novel Nonsense Mutation in the SACS Gene
por: Agarwal, Ayush, et al.
Publicado: (2020)

Clinical Characterization of a 6-Year-Old Patient with Autism and Two Adjacent Duplications on 10q11.22q11.23. A Case Report
por: Tritto, Giovanna, et al.
Publicado: (2021)

Decreased Levels of Erythrocyte Membrane Arachidonic and Docosahexaenoic Acids Are Associated With Retinopathy of Prematurity
por: Gillespie, Tessa C., et al.
Publicado: (2022)

Dynamics of Docosahexaenoic Acid Utilization by Mouse Peritoneal Macrophages
por: Monge, Patricia, et al.
Publicado: (2023)

Docosahexaenoic Acid and Cognition throughout the Lifespan
por: Weiser, Michael J., et al.
Publicado: (2016)

The Role of Docosahexaenoic Acid (DHA) on Cognitive Functions in Psychiatric Disorders
por: Ciappolino, Valentina, et al.
Publicado: (2019)

Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report
por: Terre'Blanche, Gisella, et al.
Publicado: (2011)

Docosahexaenoic Acid Induces Apoptosis in Primary Chronic Lymphocytic Leukemia Cells
por: Guièze, Romain, et al.
Publicado: (2015)

Effects of a Nutritional Formulation Containing Caprylic and Capric Acid, Phosphatidylserine, and Docosahexaenoic Acid in Streptozotocin-Lesioned Rats
por: Moura, Eric L.R., et al.
Publicado: (2020)

Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38
por: Manes, Marta, et al.
Publicado: (2017)

Production of docosahexaenoic acid by Aurantiochytrium sp. ATCC PRA-276
por: Furlan, Valcenir Júnior Mendes, et al.
Publicado: (2017)

Long term follow-up in two siblings with Sengers syndrome: Case report
por: Panicucci, Chiara, et al.
Publicado: (2022)

Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke
por: Belayev, Ludmila, et al.
Publicado: (2010)

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
por: Russell, Fraser D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dfjtv05ft7s2lkousn5glsfpb7